Posted 21 september 2015 in Okategoriserade
A new control system for our in vitro Air Liquid Interface (ALI) cell culture module XposeALI lets us pre-set and regulate airflow more exactly through the system, meaning greater…
Read morePosted 15 september 2015 in Okategoriserade
Our new pre-separator removes coarse lactose particles larger than 5 µm before they reach PreciseInhale’s main holding chamber. The pre-separator aims for a 50% cut-off at 5 µm,…
Read morePosted 15 september 2015 in Okategoriserade
(July 2015) Here’s the prototype of the new in vivo docking table we’ve designed. Both the height and angle of the table can easily be adjusted (unlike other…
Read morePosted 02 september 2015 in Okategoriserade
Do you want a leading role in the next generation of inhalation R&D technology, enabling pharma clients to cut their drug development timelines in one of the world’s…
Read morePosted 02 september 2015 in Okategoriserade
Do you want a leading role in the next generation of inhalation R&D technology, enabling pharma clients to cut their drug development timelines in one of the world’s…
Read morePosted 15 juli 2015 in Okategoriserade
Swetox has chosen ISAB’s precision dosing PreciseInhale system for research into the effects of inhaled Endocrine Disrupting Compounds (EDCs). Swetox is an innovative, interdisciplinary environmental research center combining…
Read morePosted 15 juli 2015 in Okategoriserade
Swetox has chosen ISAB’s precision dosing PreciseInhale system for research into the effects of inhaled Endocrine Disrupting Compounds (EDCs). Swetox is an innovative, interdisciplinary environmental research center combining…
Read morePosted 25 juni 2015 in Okategoriserade
ISAB is broadening its ownership base with a significant initial capital investment from prestigious venture finance companies Stockholms Affärsänglar (STOAF) and Almi Invest, who both become new minority share…
Read morePosted 25 juni 2015 in Okategoriserade
ISAB is broadening its ownership base with a significant initial capital investment from prestigious venture finance companies Stockholms Affärsänglar (STOAF) and Almi Invest, who both become new minority share…
Read morePosted 05 juni 2015 in Okategoriserade
After three years in IT, three with Octapharma and ten with Pharmacia/Pfizer, analytical chemist Mattias Nowenwik has joined the ISAB team at our labs in Stockholm. Mattias brings…
Read more